Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome

• Status: Completed
• Trial end date: 2007-10-15
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• Must have irritable bowel syndrome.

Exclusion criteria:

• Subjects who have been taking any medication for the treatment of irritable bowel syndrome within 6 months prior to the start of the study.